The United States has terminated all HIV-related funding for South Africa, a decision that threatens to unravel decades of progress in the fight against the epidemic. The move, confirmed by the US Agency for International Development, ends support for the President's Emergency Plan for AIDS Relief (PEPFAR) programmes in the country, which had provided antiretroviral drugs to more than 7 million people.
The decision places at immediate risk the lives of millions reliant on treatment, and weakens the broader public health infrastructure in a country that accounts for roughly one-fifth of the global HIV burden. South Africa has the largest HIV epidemic in the world, with an estimated 8.2 million people living with the virus. The US funding cut includes not only treatment but also prevention, testing, and care services.
The termination of aid appears to be part of a broader reassessment of US foreign assistance, though the sudden nature and the scale of the impact have drawn sharp criticism. South African health officials were given no prior warning, leaving them scrambling to secure alternative funding sources. The US has been the largest bilateral donor to South Africa's HIV response, contributing approximately $600 million annually in recent years.
Health experts warn that the abrupt halt could lead to treatment interruptions, increased viral resistance, and a resurgence of new infections. Dr. Thabo Mbeki, a leading epidemiologist at the University of Cape Town, described the decision as "catastrophic" for the thousands of patients who rely on US-funded clinics and supply chains. "This is not simply a funding gap. It is a breach of trust that undermines years of partnership," he said.
The timing is particularly precarious given that South Africa is still recovering from the economic and health impacts of the COVID-19 pandemic. The country's public health system, already strained, now faces an additional burden. The Department of Health has announced it will prioritise maintaining treatment access, but acknowledges that the loss of US support is a severe blow.
Observers note that the decision may have geopolitical implications. China and Russia have increasingly deepened engagement with African nations, and the US withdrawal from a key health partnership could be seen as a retreat from soft power influence on the continent. South Africa has made clear its intention to seek alternative donors, including the Global Fund to Fight AIDS, Tuberculosis and Malaria, and potentially new arrangements with the BRICS bloc.
The US administration has not provided a detailed rationale for the cut, beyond citing a routine review of foreign aid efficacy. Critics argue, however, that the move appears abrupt and ill-considered. The US Congress had previously signalled continued support for PEPFAR, which has been widely regarded as one of the most successful global health initiatives in history.
For now, South Africa's HIV response faces an uncertain future. The government has pledged to maintain treatment coverage through domestic resources, but fiscal constraints make this a daunting prospect. The long-term consequences for millions of patients, and for the region's stability, remain to be seen.